InvestmentParticipated in Xsensio's $7M Series A for continuous biochemical monitoring wearables.XsensioXsensioPrivilège Venturesbioalps.orgMAR 3, 2026MAR 3, 2026
NewsFounder Jacqueline Ruedin Rüsch recognized among Europe's top 100 most influential women in startup and VC for the second consecutive year.Jacqueline Ruedin Rüsch named Europe's top 100 influential women in VC
InvestmentSupported Annaida's pre-Series A funding round as EIC Transition beneficiary.AnnaidaAnnaidaPrivilège Venturesprivilege-ventures.comJUL 2025JUL 2025
InvestmentLed Adiposs's CHF 4M Series A for diagnostic imaging and cancer care monitoring.AdipossAdipossPrivilège Venturesprivilege-ventures.comJUN 2025JUN 2025